Please see below for a list of search results.
This policy sets out the legal requirements of the HT Act with regard to consent for post-mortem examination, tissue retention and storage of tissue from the deceased.
The Policy, Strategy and Communications (PoSC) Directorate contributes to the delivery and development of the HTA’s aims. As such, PoSC is involved in a wide range of work and projects across the organisation.
Guidance for establishments on meeting HTA licensing requirements for the procurement of tumour samples to be used as a starting material in the manufacture of an Advanced Therapy Medicinal Product (ATMP).
Issued March 2010 Umbilical cord blood (cord blood) is collected at the time of birth and stored so that it may be available for potential future treatment of the child or another person.
Issued 17 August 2009